Clinical Trial Update: Repeated Mesenchymal Stem Cell Injections in ALS [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating repeated mesenchymal stem cell injections in adults with amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: COMPLETED